An old debate still in the β-phase?
Eur J Heart Fail
.
2018 Mar;20(3):557-559.
doi: 10.1002/ejhf.1086.
Epub 2018 Jan 12.
Authors
Arantxa Barandiarán Aizpurua
1
2
,
Frits M E Franssen
3
4
,
Vanessa van Empel
1
2
,
Hans-Peter Brunner-La Rocca
1
2
Affiliations
1
Department of Cardiology, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.
2
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.
3
Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, the Netherlands.
4
Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.
PMID:
29327802
DOI:
10.1002/ejhf.1086
No abstract available
Publication types
Editorial
Comment
MeSH terms
Adrenergic beta-Antagonists / therapeutic use*
Heart Failure / complications*
Humans
Pulmonary Disease, Chronic Obstructive / complications*
Substances
Adrenergic beta-Antagonists